Foghorn Therapeutics Inc. (FHTX) Operating margin 2020–2025
Foghorn Therapeutics Inc. (FHTX) operating margin by fiscal year — reported operating income divided by reported revenue.
-279.5%FY2025 · since FY2020: -15937.4% → -279.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -279.5% | +174.8 pp |
| FY2024 | -454.3% | -138.4 pp |
| FY2023 | -315.9% | +293.3 pp |
| FY2022 | -609.2% | +7027.9 pp |
| FY2021 | -7637.1% | +8300.3 pp |
| FY2020 | -15937.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More FHTX financial trends
FHTX RevenueFHTX Net incomeFHTX Net marginFHTX Gross profitFHTX Gross marginFHTX Operating incomeFHTX Operating cash flowFHTX Free cash flowFHTX Capital expendituresFHTX Return on equityFHTX Stock buybacksFHTX Dividends paidFHTX Total assetsFHTX Total liabilitiesFHTX Shareholders’ equityFHTX overview →